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Objective: It has been forecasted that the rabbiteye blueberry could inhibit osteoporosis. However, the inhibition
and prevention of osteoporosis via rabbiteye blueberry are still elusive. This study was aim to evaluate the
anti-osteoporosis effects of rabbiteye blueberry in ovariectomized rats.
Methods: Thirty rats were randomly divided into three groups of ten rats each as follows: sham-operated group
(SG), ovariectomized model control group (OMG), and ovariectomized rabbiteye blueberry treatment group (OBG).
The blood mineral levels, the alkaline phosphatase (ALP) activity, and osteoprotegerin (OPG) level were determined.
The expression analyses of type I collagen, integrin-β1, and focal adhesion kinase (FAK) were performed. Besides,
the bone mineral density (BMD) and bone histomorphometry (BH) were measured.
Results: The ALP activity in SG and OBG was significantly lower than that in OMG. For the OPG level, the significant
increase of OPG level in OBG was indicated compared with the other groups. The mRNA expression levels of type I
collagen, integrin-β1, and FAK in OMG were significantly lower than those in other groups. The BMD in OMG were
all significantly lower than those in SG and OBG. For BH, blueberry significantly improved the trabecular bone
volume fraction, trabecular thickness, mean trabecular bone number, and bone formation rate, and decreased the
trabecular separation, the percent of bone resorption perimeter, and mean osteoclast number in OBG compared
with OMG.
Conclusions: The rabbiteye blueberries had an effective inhibition in bone resorption, bone loss, and reduction
of bone strength of ovariectomized rats and could improve the BMD, osteogenic activity, and trabecular bone
structure.
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histomorphometryIntroduction
Osteoporosis is a systemic skeletal disease characterized
by low bone mass and microarchitectural deterioration
of bone tissue, with a consequent increase in bone fra-
gility and susceptibility to fracture [1]. In the USA, there
are 10 million Americans with osteoporosis (8 million
women and 2 million men) and another 34 million indi-
viduals with osteopenia, which resulted in a significant
proportion of the population to be deemed ‘at risk’ [2].
The major current anti-osteoporotic therapy is pharma-
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unless otherwise stated.selective estrogen receptor modulators, and parathyroid
hormone [3]. In the past 5 years, additional drugs were
likely to have been approved, such as the anti-RANK
ligand monoclonal antibody [4] and cathepsin K inhibitors
[5]. Most of the pharmacologic therapy strategies have
been adopted that aim to inhibit excessive bone resorption
and increase bone formation. There were also manage-
ments focused on non-pharmacologic treatments, such as
a balanced diet and adequate calcium and vitamin D in-
take [6]. Folic acid [7], vitamin B12 [8], carotenoid [9], and
lycopene [10] have been reported effective in improving
bone loss and relieving the symptoms of osteoporosis in
postmenopausal women [11].
Rabbiteye blueberry (Vaccinium ashei Reade) is a highly
heterozygous, cross-pollinating fruit species, and belongshis is an Open Access article distributed under the terms of the Creative
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family. Recent reports showed that feeding a high-quality
diet supplemented with blueberries to pre-pubertal rats or
the rats at postnatal day 20 to 34 prevented ovariectomy-
induced bone loss in adult life [12]. The molecular mecha-
nisms underlying these effects may involve the increase of
myosin production and reduction of mesenchymal stro-
mal cell senescence. However, the effect of blueberry diet
on inhibiting ovariectomy-induced osteoporosis and its
mechanisms still need research.
In order to provide more evidence and gain a better
understanding on the association between the active
ingredients of rabbiteye blueberries and the inhibition of
ovariectomy-induced osteoporosis, in vivo experiments
on ovariectomized rat models have been conducted in
this study. The blood mineral levels, the activity of alka-
line phosphatase (ALP), and osteoprotegerin (OPG) level
were determined to evaluate the effect of rabbiteye blue-
berry to osteoporosis. The expression analysis of type I
collagen, integrin-β1, and focal adhesion kinase (FAK)
was performed to explore the influence of rabbiteye blue-
berries on the osteoporosis-related integrin pathway. Fur-
ther measurements of bone mineral density (BMD) and
bone histomorphometry (BH) were performed to observe




Our experimental research on animals followed interna-
tionally recognized guidelines. The Animal Ethics Commit-
tee of Shanghai Jiao Tong University School of Medicine
approved the study (reference number 2010–0018).
A total of 30 normal 8-week-old female Sprague–
Dawley rats (160 ± 15 g) were provided by the Labora-
tory of Animal Science Department of Shanghai Jiao
Tong University School of Medicine. The 30 rats were
housed in ten cages with temperature of 21°C ± 1°C,
relative humidity of 60%, ambient noise <50 dB, and
regular 12-h light cycle. All rats were feed with conven-
tional food and free access to water.
Operative techniques
The 30 rats were randomly divided into three groups
of ten rats each as follows: sham-operated group (SG),
ovariectomized model control group (OMG), and ovari-
ectomized blueberry treatment group (OBG). All rats
were anesthetized before operation by intraperitoneal in-
jection with 1% (volume fraction) pentobarbital sodium
at a dose of 40 mg/kg. The operation begun through a
1-cm longitudinal incision at the back, 1 cm from the
spine and 2 cm above the posterior iliac crest. Bilateral
oophorectomy was performed on the rats of OMG and
OBG, while same weights of greater omentums wereremoved instead of ovary for the rats of SG. Finally,
the wound was closed in layers after stump ligation.
Rabbiteye blueberry administration
After the operation, penicillin was intramuscularly
injected to all the rats for three consecutive days. One
week later, the rats in the OBG were administered with
freeze-dried blueberry powder water solution (10%, w/w)
for 12 consecutive weeks by gavage, while the rats in the
SG and OMG were administered with equal volume
of double distilled water by gavage. The freeze-dried
blueberry powder (stored at −20°C) was provided by
the Institute of Botany, Chinese Academy of Sciences,
Beijing, China.
Determination of the levels of serum minerals, ALP,
and OPG
After the 12-week administration, the rats were anesthe-
tized by intraperitoneal injection of 20% (w/v) urethane
solution at a dose of 1 mg/kg. The blood samples were
collected from the abdominal aorta and then the serum
was obtained by centrifugation at a low temperature of
4°C. The levels of the serum minerals were determined
by using an automatic biochemical analyzer. The ALP
activity was determined using an Alkaline Phosphatase
Opt Kit (Roche Molecular Biochemical, Indianapolis, IN,
USA). The OPG level in serum was measured by ELISA
using the Biomedical rat OPG ELISA kit (Biomedical,
Wien, Austria). All measurements were performed
according to the manufacturer’s instructions.
Total RNA extraction and reverse transcription of RNA
After being fasted for 24 h, all the rats were sacrificed.
Then, the third lumbar vertebra without surrounding
soft tissues was quickly collected at once. After homoge-
nized treatment, the total RNA was extracted by using
Trizol Reagent (Shanghai Jianglai Biotechnology Co.,
Ltd., Shanghai, China) according to the manufacturer’s
recommendations. The quantity and quality of RNA were
determined by UV absorbance at 260-, 280-, and 320-nm
wavelengths using NanoDrop ND-1000 (Thermo Fisher
Scientific Inc., Waltham, MA, USA). Complementary
DNA (cDNA) was synthesized from RNA using Reverse-
transcription kit (Life Technologies Company, Beijing,
China) with Superscript II Reverse Transcriptase (Life
Technologies Inc., CA, USA) according to the manufac-
turer’s recommendations.
Detection of expression of type I collagen, integrin-β1,
and focal adhesion kinase
The real-time quantitative polymerase chain reaction
(PCR) was carried out by CFX96 Real-Time PCR ins-
trument (Bio-Rad, Hercules, CA, USA). SYBR Green I
was provided by Shanghai Life Technology Company
Table 1 Primers of collagen-1, integrin-β1, FAK, and β-actin




β-actin TCT TCC AGC CTT CCT TCC TG TAG AGC CAC CAA TCC ACA CA
Collagen-1 encodes type I collagen, integrin-β1 encodes integrin-β1, and FAK encodes focal adhesion kinase.
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I collagen), integrin-β1 (encoding integrin-β1), FAK
(encoding focal adhesion kinase), and β-actin were
shown in Table 1. The real-time quantitative PCR was
carried out under the following conditions: preheating
at 95°C for 5 min, followed by 45 cycles of denaturation
at 95°C for 1 min, annealing at 54°C for 1 min, and
extension at 74°C for 2 min. The PCR amplification
was ended by a final extension cycle at 72°C for 10 min.
After obtaining the amplification curve and the CT
values, the dissolve curve was analyzed using the fol-
lowing setting: 95°C for 15 s, 60°C for 1 min, and 95°C
for 15 s. The relative expression of each biomarker was
represented as the radio of the copy number of each
sample and β-actin.Detection of BMD
The left femur BMD was measured by using EXA-3000
dual-energy X-ray BMD measure instrument (MEDILINK,
Mauguio, France). Based on actual length measured by
the measuring instrument, the left femur BMD was di-
vided into three parts: the proximal BMD (pBMD) in the
upper portion including one fourth of the femur, the mid-
dle (mBMD) in middle portion including one half of the
femur, and the distance (dBMD) in the lower end portion
including one fourth of the femur.Table 2 The levels of serum minerals (Ca, P, and Mg) in
each group
Name OMG SG OBG
Ca (mmol/L) 2.20 ± 0.16 2.34 ± 0.08 2.22 ± 0.21
P (mmol/L) 1.62 ± 0.24 1.71 ± 0.17 1.82 ± 0.14
Mg (mmol/L) 0.63 ± 0.11 0.52 ± 0.08 0.53 ± 0.12
OMG ovariectomized model control group, SG sham-operated group, OBG
ovariectomized rabbiteye blueberry treatment group.Detection of histomorphometry
The complete right femur and tibia were used to prepare
bone specimens for analyzing BH. The bone specimens
were stained by von Kossa and Giemsa before they were
observed and imaged by fluorescent/optical microscope
(Leica DM4000B, Stuttgart, Germany). Randomly selec-
ted images in the inner, middle, and outer of the speci-
men were saved.
Static and dynamic histomorphometric measurements
of the secondary cancellous bone located within 4.0 mm
distal to the growth plate-metaphyseal were performed.
The specimens stained with von Kossa were used for
histology observation, while the specimens stained with
Giemsa were used to observe osteoid. The data of BH
were analyzed by using a color image analysis software
of Leica.Statistical analysis
The SPSS 12.0 software (http://www-01.ibm.com/software/
analytics/spss/) was used for the statistical analysis. The
results were all expressed as mean ± SEM. The analysis
of variance and multiple comparison tests were per-




The serum minerals were monitored for changes that
may affect bone mineralization. The levels of serum mi-
nerals (Ca, P, and Mg) in each group were shown in per-
centages (Table 2). The results indicated that there was
no significant difference in the levels of serum minerals
(Ca, P, and Mg) among the three groups with p value of
more than 0.05.
OPG level and ALP activity
The ALP activity in SG and OBG was significantly lower
than that in OMG (SG vs. OMG: p = 0.035; OBG vs.
OMG: p = 0.041), and there was no significant difference
between SG and OBG. For the OPG level in the serum,
the significant increase of OPG level in OBG was indi-
cated when compared with the other groups (OBG vs.
SG: p = 0.029). The OPG level in SG was significantly
lower than that in OMG (Figure 1).
The mRNA expression levels of type I collagen, integrin-β1,
and FAK
Compared with the OMG, the mRNA expression levels
of type I collagen, integrin-β1, and FAK were significantly
higher in the OBG and SG (type I collagen: SG vs. OMG,
p = 0.005; OBG vs. OMG, p = 0.001; integrin-β1: SG vs.
Figure 1 The alkaline phosphatase (ALP) activity and osteoprotegerin (OPG) level in each group (n = 10). The activity (right image) and
level (left image) were compared with those in the ovariectomized model control group (*p < 0.05, **p < 0.01) and compared with those in the
sham-operated group (#p < 0.05). Model: ovariectomized model control group (OMG); sham: sham-operated group (SG); blueberry: ovariectomized
blueberry treatment group (OBG).
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OMG, p = 0.008; OBG vs. OMG, p = 0.001). Moreover,
their mRNA expression levels in OBG were significantly
increased compared with those in SG (type I collagen:
OBG vs. SG, p = 0.001; integrin-β1: OBG vs. SG, p = 0.001;
FAK: OBG vs. SG, p = 0.001) (Figure 2).Comparison of BMD
The total BMD, pBMD, mBMD, and dBMD in OMG
were all significantly lower than those in SG (total BMD:
p = 0.012; pBMD: p = 0.025; mBMD: p = 0.016; dBMD:
p = 0.021). Compared with the OMG, the total BMD,
pBMD, mBMD, and dBMD were all significantly increased
in OBG (total BMD: p = 0.028; pBMD: p = 0.036; mBMD:
p = 0.045; dBMD: p = 0.042) (Figure 3).Figure 2 mRNA expression levels of type I collagen, integrin-β1,
and FAK in each group (n = 10). The levels were compared with
those in the ovariectomized model control group (*p < 0.01) and
compared with those in the sham-operated group (#p < 0.01). Model:
ovariectomized model control group (OMG); sham: sham-operated
group (SG); blueberry: ovariectomized blueberry treatment
group (OBG).Bone histomorphology
The statistical analysis for the results of histomorpho-
metric measurements indicated that the static and
dynamic parameters of BH in SG and OBG presented
significant differences compared with the OMG. The
trabecular bone volume fraction (trabecular bone vol-
ume (BV)/total tissue volume (TV)), trabecular thick-
ness (Tb. Th), and mean trabecular bone number (Tb. N)
in OBG and SG were significant higher than those in
OMG (p < 0.01). The trabecular separation (Tb. Sp), the
percent of bone resorption perimeter (ES/BS), and the
mean osteoclast number (Oc. N) in OBG and SG were
significantly lower than those in OMG (p < 0.05). The
osteoid perimeter (O. Pm) in SG was significantly lower
than that in OMG (p < 0.05), while there was no signifi-
cant difference in the osteoid perimeter between OBG
and OMG. The fluorescent tag circumference ratio
(L. Pm) was significantly lower in SG than in OMG
(p < 0.01) but significantly higher in OBG than in
OMG (p < 0.05). The bone formation rate (BFR/BV)
in OBG and SG was higher than that in OMG (p < 0.01)
(Table 3).Discussion
Osteoporosis is a systemic skeletal disease that is often
accompanied with a decrease of bone mass and micro-
architectural deterioration of bone tissue, which can lead
to an enhanced bone fragility and consequent increase
in fracture risk [13]. The risk is greater in postmeno-
pausal women due to deficiency of estrogen [14], which
was considered the seminal mechanism of osteoporosis
in both women and men [15]. Thus, a further under-
standing on osteoporosis pathogenesis, combined with
the development of treatments with proven efficacy, will
increase demand for the more effective management of
patients with osteoporosis [16]. The lyophilized rabbiteye
blueberries have been reported to have antioxidant
activity [17] and can affect lipid metabolism [18]. In
addition, it was reported that GTP supplementation plus
Figure 3 Bone mineral density of rats in each group (n = 10).
The BMD was compared with that in the ovariectomized model
group (*p < 0.05). Model: ovariectomized model control group
(OMG); sham: sham-operated group (SG); blueberry: ovariectomized
blueberry treatment group (OBG).
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decrease of oxidative stress [19]. Therefore, its antioxi-
dant activity may be one of the mechanisms for prevent-
ing osteoporosis. However, there are few studies focusing
on the preventive effects of rabbiteye blueberries on post-
menopausal osteoporosis which is the most common
cause of age-related bone loss.
Ovariectomy-induced bone loss and postmenopausal
bone loss in the rat share many similar characteristics
[20]. Thus, the ovariectomy-induced osteoporosis in rat
was used as a model for postmenopausal osteoporosis in
humans in this study. Bone mineral mainly includes Ca,
P, and Mg, and bone metabolism can be indirectly stud-
ied through their levels in the serum. In this study, their
levels presented no significant difference among theTable 3 Results of bone histomorphometry in each group
OMG SG
BV/TV (%) 16.38 ± 5.69 29.47 ± 6.52*
Tb. Th (μm) 48.96 ± 8.64 85.36 ± 9.35*
Tb. N (L/mm) 1.69 ± 0.16 2.05 ± 0.16*
Tb. Sp (μm) 763.85 ± 138.24 369.42 ± 102.34*
ES/BS (%) 18.27 ± 4.82 9.50 ± 4.42*
Oc. N (L/mm2) 0.26 ± 0.08 0.10 ± 0.06*
O. Pm (%) 30.35 ± 6.32 18.84 ± 6.47**
L. Pm (%) 15.03 ± 1.26 8.63 ± 1.09*
BFR/BV (%/year) 36.85 ± 6.23 58.27 ± 7.03*
*p < 0.01 and **p < 0.05 compared with the OMG. OMG ovariectomized model cont
treatment group, BV/TV trabecular bone volume fraction (trabecular bone volume (B
bone number, Tb. Sp trabecular separation, ES/BS the percent of bone resorption perim
tag circumference ratio, BFR/BV bone formation rate.three groups. The reason may be that the loss of bone
mineral presents as a slow process due to a more active
bone resorption than bone formation in the ovariecto-
mized rats.
The ALP activity in the OMG presented a sharp rise
compared with those in the other groups and no signifi-
cant difference between OBG and SG, suggesting that
the rabbiteye blueberry diet played a bone-protective
role in the ovariectomized rat model. Moreover, the
OPG level in OBG was significantly increased compared
with those in the OMG and SG. It is well known that
the balance between bone formation and bone resorp-
tion is essential for bone mass and bone microstructure
[21]. ALP is assessed as a marker of bone formation
[22], while OPG is identified as an inhibitor of osteoclas-
togenesis, osteoclast differentiation, and activation both
in vitro and in vivo [23]. Significantly lower ALP ac-
tivity and higher OPG level in OBG than in OMG
were detected, revealing that rabbiteye blueberry can
prevent osteoblast development by increasing the OPG
level and can prevent osteoporosis by inhibiting the
ALP activity.
Integrins are heterodimeric transmembrane proteins
consisting of α and β subunits that functionally serve as
both adhesive and signaling receptors [24]. Integrin-β1
is a major receptor of matrix glycoproteins in type I
collagen-induced osteoblastic differentiation of bone mar-
row cells [25]. Type I collagen interacts with integrin-β1
receptor on the cell membrane, mediates extracellular sig-
nals into cells, and activates the FAK signal pathway. FAK
is the immediate transducer in integrin-β1-dependent ad-
hesion of osteoblasts to bone matrices [26]. In this study,
we observed that the mRNAs of type I collagen, integrin-
β1, and FAK in OMG expressed less than those in SG and
OBG, and they expressed more in OBG than in SG. Ovari-
ectomy could induce estrogen deficiency and increasep value OBG p value
0.001 22.39 ± 5.26* 0.005
0.001 72.96 ± 7.37* 0.002
0.005 1.89 ± 0.11* 0.008
0.001 587.56 ± 185.21* 0.008
0.007 14.27 ± 4.23** 0.044
0.001 0.20 ± 0.05** 0.039
0.030 31.13 ± 5.08 -
0.001 16.98 ± 3.25** 0.041
0.002 61.23 ± 13.91* 0.001
rol group, SG sham-operated group, OBG ovariectomized rabbiteye blueberry
V)/total tissue volume (TV)), Tb. Th trabecular thickness, Tb. N mean trabecular
eter, Oc. N mean osteoclast number, O. Pm osteoid perimeter, L. Pm fluorescent
Li et al. Journal of Orthopaedic Surgery and Research 2014, 9:56 Page 6 of 7
http://www.josr-online.com/content/9/1/56bone resorption which led to accelerated collagen degrad-
ation and reduced collagen synthesis, especially type I col-
lagen [27,28]; then, the expression of integrin-β1 and FAK
may be affected. The reason may be that the mRNA ex-
pression levels of type I collagen, integrin-β1, and FAK in
the model rats were decreased in OMG. Meanwhile, the
mRNA expression levels of type I collagen, integrin-β1,
and FAK in OBG were significantly higher than those in
the other groups, indicating that rabbiteye blueberry
played a positive role in preventing osteoporosis. The
integrin-β1/FAK signaling pathway may be repaired by
active ingredients in blueberry to induce the increase of
osteogenic activity.
Bone strength is determined by bone mass and bone
quality. Bone mass is estimated in clinical practice by
measuring the BMD. Menopause is the largest contribu-
tor to decreasing bone mineral density due to the signifi-
cant decrease of estrogen [29]. The total BMD, pBMD,
mBMD, and dBMD in OMG were all significantly lower
than those in SG, and blueberry increased the BMD in
OBG compared with OMG. This indicated that blue-
berry could effectively improve BMD of ovariectomized
rats. Compared to BMD, BH can reflect the bone quality
including bone microstructure and dynamic changes of
bone metabolism. Trabecular bone belongs to cancellous
bone, which is more sensitive to osteopenia than the
cortical bone [30]. The trabecular architecture becomes
more rod-like and anisotropic in osteoporotic and aging
trabecular bone [31,32], even completely disappears in
postmenopausal women and ovariectomized rats [33]. In
this study, rabbiteye blueberries significantly improved
the trabecular bone volume fraction, trabecular thick-
ness, and mean trabecular bone number, and decrease
the trabecular separation in OBG compared with OMG.
Thus, the active ingredients in blueberry could prevent
the loss of trabecular bone in osteoporosis.
It was reported that the decrease of estrogen enhanced
the osteoclast development and increased the number of
osteoclasts in the trabecular bone [34]. According to the
results of this study, the percent of bone resorption
perimeter and mean osteoclast number in OBG and SG
were significantly lower than those in OMG, and the
bone formation rate in OBG and SG were higher than
that in OMG, indicating that the blueberry effectively
inhibited the development of osteoclast and bone re-
sorption and promoted bone formation. However, the
osteoid perimeter and the fluorescent tag circumference
ratio in SG were significantly lower than that in OMG,
and blueberry did not inhibit their increase in OBG. The
active ingredients in blueberries were complex. There
may be some ingredients that can affect the osteoid per-
imeter and the fluorescent tag circumference ratio. More
studies were required to explore the active ingredients in
blueberries for preventing osteoporosis.Conclusion
In conclusion, we have validated the inhibition of rab-
biteye blueberry on ovariectomy-induced osteoporosis
in vivo. The results showed that the rabbiteye blue-
berries had an effective inhibition in bone resorption,
bone loss, and reduction of bone strength of ovariecto-
mized rats, and could improve the BMD, osteogenic activ-
ity, and trabecular bone structure. Therefore, we conclude
that blueberry might prevent and inhibit ovariectomy-
induced osteoporosis, which provides new basis for the
clinical treatment of osteoporosis. We showed, for the first
time, that rabbiteye blueberries have great potential to
accurately, reliably, and safely improve osteoporosis in a
rat model of ovariectomy-induced osteoporosis.
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